Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

6.850 +0.020 (+0.29%)
Streaming Delayed Price Updated: 9:50 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 Next >
Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views
Following the market opening Thursday, the Dow traded down 0.11% to 34,352.56 while the NASDAQ climbed 0.44% to 14,576.37. The S&P also rose, gaining 0.15% to 4,365.81. The U.... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:... 
Via Benzinga
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For September 30, 2021
Companies Reporting Before The Bell • Antelope Enterprise Hldgs (NASDAQ:AEHL) is likely to report earnings for its first quarter. • Paychex (NASDAQ:PAYX) is... 
Via Benzinga
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
From AngioDynamics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021
Upgrades For Investors Bancorp Inc (NASDAQ: 
Via Benzinga
AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
After Beating Estimates, Is This Little-Known Medical Device Company a Buy?
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying? 
Via The Motley Fool
Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript
ANGO earnings call for the period ending May 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
AngioDynamics Breaks-Even In FY21, Issues Mixed Forecasts For FY22
AngioDynamics Inc (NASDAQ: ANGO) reports break-even in 4Q of 2021 with adjusted EPS of $0.00, a turnaround from EPS of (0.06) posted a year ago. The Company... 
Via Benzinga
AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
From AngioDynamics, Inc.
Via Business Wire
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical... 
Via Benzinga
Earnings Scheduled For July 13, 2021
Companies Reporting Before The Bell • OrganiGram Holdings (NASDAQ:OGI) is estimated to report quarterly loss at $0.03 per share on revenue of $13.95 million. •... 
Via Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback... 
Via Benzinga
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
From AngioDynamics, Inc.
Via Business Wire
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Exposures COVID-19
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
From AngioDynamics, Inc.
Via Business Wire
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
From AngioDynamics, Inc.
Via Business Wire
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.